SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001654954-23-014367
Filing Date
2023-11-14
Accepted
2023-11-14 16:31:21
Documents
4

Document Format Files

Seq Description Document Type Size
1 FORM 424B3 tenx_424b3.htm 424B3 27010
2 EX-99.1 tenx_ex991.htm EX-99.1 16087
3 tenx_ex991img3.jpg GRAPHIC 2880
4 tenx_424b3img1.jpg GRAPHIC 4492
  Complete submission text file 0001654954-23-014367.txt   54805
Mailing Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517
Business Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517 919-855-2100
TENAX THERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

IRS No.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-269363 | Film No.: 231407039
SIC: 2834 Pharmaceutical Preparations